Specifications:
Item Type: Targeted therapy (IDH1 inhibitor)
Also Known As: Oral capsule, twice daily
Storage: olutasideniboC
Condition: New
Notable Specs & Safety: Boxed warning for differentiation syndrome; requires IDH1 test confirmation
Product Code: PDC-MED-725164
Ratings:
Views:
Product Description:
Rezlidhia is an oral medicine used for adults with relapsed or refractory AML that has an IDH1 mutation. It works by inhibiting mutant IDH1 enzymes, which may help normal blood cell development resume. Given by mouth, often as part of a comprehensive leukemia treatment plan.
Why Choose Demicon Trading
Quality
You can TrustOntime
GuaranteeCheap
DeliveryReturn Policy
GuaranteedDelivery Options & Overview
1. Order the Product and Sepcify the Delivery Method
2. You wil receive an Order Confirmation Message
3. Pay & Wait for arrival Notification by call or email
4. Product is delivered to your address
Shop by Category
Partners
